PFIZER DRN (Brazil) Valuation


BRL 59.17  1.92  3.35%   

Do you wonder what the value of PFIZER DRN is? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as PFIZER DRN, is its stock price multiplied by the total number of shares outstanding, calculating PFIZER DRN's enterprise value requires a different approach. It uses PFIZER DRN's balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
PFIZER DRN holds a recent Real Value of R$54.96 per share. The prevailing price of the company is R$59.17. At this time, the company appears to be fairly valued. Our model determines the value of PFIZER DRN from evaluating the company fundamentals such as operating margin of 37.61 %, and Return On Equity of 31.87 % as well as inspecting its technical indicators and Probability Of Bankruptcy. In general, we support taking in undervalued entities and trading overvalued entities since, in the future, asset prices and their ongoing real values will merge together.
PFIZER DRN Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as PFIZER DRN's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.
Fairly Valued
Today 59.17
Please note that PFIZER DRN's price fluctuation is very steady at this time. Calculation of the real value of PFIZER DRN is based on 3 months time horizon. Increasing PFIZER DRN's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for PFIZER DRN is useful when determining the fair value of the PFIZER stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of PFIZER DRN. Since PFIZER DRN is currently traded on the exchange, buyers and sellers on that exchange determine the market value of PFIZER Stock. However, PFIZER DRN's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Real Value
Estimating the potential upside or downside of PFIZER DRN helps investors to forecast how PFIZER stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of PFIZER DRN more accurately as focusing exclusively on PFIZER DRN's fundamentals will not take into account other important factors:
Band Projection (param)
LowerMiddle BandUpper
LowEstimated ValueHigh
Annual Dividend
LowIncome Per ShareHigh

PFIZER DRN Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining PFIZER DRN's current stock value. Our valuation model uses many indicators to compare PFIZER DRN value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across PFIZER DRN competition to find correlations between indicators driving PFIZER DRN's intrinsic value. More Info.
PFIZER DRN is considered to be number one stock in five year return category among related companies. It is considered to be number one stock in beta category among related companies totaling about  0.20  of Beta per Five Year Return. The ratio of Five Year Return to Beta for PFIZER DRN is roughly  5.07 . Comparative valuation analysis is a catch-all model that can be used if you cannot value PFIZER DRN by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for PFIZER DRN's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the PFIZER DRN's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates PFIZER DRN's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in PFIZER DRN and how it compares across the competition.

About PFIZER DRN Valuation

The stock valuation mechanism determines the current worth of PFIZER DRN on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of PFIZER DRN. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of PFIZER DRN based exclusively on its fundamental and basic technical indicators. By analyzing PFIZER DRN's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of PFIZER DRN's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of PFIZER DRN. We calculate exposure to PFIZER DRN's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to PFIZER DRN's related companies.
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. PFIZER DRN operates under Drug ManufacturersGeneral classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 79000 people.
Please check Your Equity Center. Note that the PFIZER DRN information on this page should be used as a complementary analysis to other PFIZER DRN's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Tools for PFIZER Stock

When running PFIZER DRN price analysis, check to measure PFIZER DRN's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PFIZER DRN is operating at the current time. Most of PFIZER DRN's value examination focuses on studying past and present price action to predict the probability of PFIZER DRN's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move PFIZER DRN's price. Additionally, you may evaluate how the addition of PFIZER DRN to your portfolios can decrease your overall portfolio volatility.
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
CEO Directory
Screen CEOs from public companies around the world
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk